Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
United States
Regional Oncology Center, Wilson, North Carolina Gabrail Cancer & Research Center, Canton, Ohio